Using Ethereum during a busy time in the winter of 2021 was like trying to navigate a huge metropolis on a single-lane road ...
A chart created by METR, a nonprofit AI organisation, has become an industrywide obsession as it measures the rapid ...
Where centralised societies excel at extraction, African fractal systems allow for circulation, reciprocity and return ...
The Pioneer on MSN
The race beyond chips: India's data opportunity
India, April 21 -- Why India Must Stop Giving Its Digital Wealth Away ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
OpenAI’s GPT-5.5 achieved a 93/100 score in ZDNET’s 10-part evaluation, showing strong performance in coding, reasoning, and creative writing. The model excelled in tasks from algorithmic ...
A paper appearing in Proceedings of the National Academy of Sciences offers a strikingly simple answer to a longstanding question: How do people learn and settle on shared social conventions, from ...
Theoretical ideas have a real-life impact,” said Michael Oser Rabin in a 2009 interview, 1 and he spent nearly seven decades ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results